Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA grants orphan drug designation for BPN-14770 as treatment of fragile X syndrome

April 4, 2018

Phase I trial of KA-34 is currently recruiting participants

April 4, 2018

Eli Lilly discovers HAVcr-2-targeting antibodies

April 4, 2018

Novel secretomes disclosed by researchers from Korea

April 4, 2018

MedImmune divulges novel anti-VEGF-A antibodies for cancer

April 4, 2018

Novartis patents new TLR7/8/9 antagonists

April 4, 2018

Retrophin initiates pivotal phase III DUPLEX study of sparsentan

April 4, 2018

FDA grants fast track designation for TAR-200 in muscle invasive bladder cancer

April 4, 2018

FDA grants BLA priority review for moxetumomab pasudotox in hairy cell leukemia

April 4, 2018

PRAME found highly expressed in salivary gland cancer

April 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...